Protein / target
1,4-alpha-glucan-branching enzyme
Protein at a glance
Biological role
Hydrolase activity, hydrolyzing O-glycosyl compounds
Strongest disease association
Glycogen Storage Disease
Research activity
Emerging research
Derived from structured UniProt, Open Targets and literature data on this page.
Protein profile
Canonical identity and biological annotation from UniProt.
Function overview
Glycogen-branching enzyme participates in the glycogen biosynthetic process along with glycogenin and glycogen synthase.
View complete UniProt function annotationHide complete annotation
Glycogen-branching enzyme participates in the glycogen biosynthetic process along with glycogenin and glycogen synthase. Generates alpha-1,6-glucosidic branches from alpha-1,4-linked glucose chains, to increase solubility of the glycogen polymer (PubMed:26199317, PubMed:8463281, PubMed:8613547)
Domains and Gene Ontology detail (11)Hide
Gene Ontology
- Ccytoplasm
- Ccytosol
- Cextracellular exosome
- F1,4-alpha-glucan branching enzyme activity
- Fcarbohydrate binding
- Fcation binding
- Fhydrolase activity, hydrolyzing O-glycosyl compounds
- Pgeneration of precursor metabolites and energy
- Pglycogen biosynthetic process
- Pglycogen metabolic process
- Pnegative regulation of neuron apoptotic process
Translational evidence
Why this target matters therapeutically, strongest evidence first. Disease associations are gene-level (via the gene that encodes this protein) and open into the full confidence synthesis; the development universe, tractability and safety annotations are target-level, from Open Targets.
Strongest disease associations · via encoding gene GBE1
Gene-level evidence surfaced through the gene GBE1that encodes this protein — not a direct protein–disease relationship. Ranked by Forefront's causal-directness weighting, so genetically- and clinically-evidenced diseases lead over ones that merely share the literature.
View evidence synthesis (3)Hide
The evidence agreement range shows how closely the independent evidence families agree — it is not a statistical confidence interval, and nothing here is fitted to outcome data. Derived from Open Targets evidence types under Forefront weighting; the per-type scores above show the calculation.
Show all associationsHide all associations
Tractability
Small molecules — Emerging
Protein degraders — Emerging
View underlying tractability evidence (3)Hide
Raw Open Targets tractability assessment buckets, by modality.
Research activity
Papers linked directly to this protein. This is the protein's own literature — descriptor-derived papers are kept separate below.
Most cited
Recent
Europe PMC papers linked directly to this protein.